Baidu suffers record profit drop after instituting new policies limiting ads on its pages following the death of a man who used treatment he found via Baidu
Context & Ripple Effects
The record profit drop is the direct bill for a crisis that began in May, when regulators opened scrutiny of Baidu's health ads after a student died using an experimental cancer treatment found through the search engine. Baidu's response — new policies limiting ads across its pages — cut into the paid-search inventory that drives its core revenue.
First-order effects
- Baidu takes an immediate earnings hit as the ad limits shrink its highest-yielding inventory, with medical advertisers losing their primary search distribution channel overnight.
- Regulators now have a demonstrated enforcement lever over Baidu's ad practices, raising compliance costs across every ad category, not just health.
Second-order effects
- Baidu's ad cleanup forces it to rebuild monetization around fewer, better-vetted listings — a trade-off that shows up again months later when it reports a second straight quarterly decline before declaring the scandal's revenue impact 'largely behind' it.
- Rival platforms and offline medical channels absorb demand that Baidu deliberately turned away, while advertisers reprice search inventory against tighter content standards.
Third-order effects
- The episode establishes that user-harm scandals can force structural retrenchment at ad-dependent platforms, not just fines — a precedent visible in Baidu's later trajectory of consecutive revenue declines, including its biggest quarterly revenue decline ever in late 2025.
- If the pattern holds, search engines operating in regulated categories face a durable choice between ad volume and regulatory legitimacy, pushing ad models toward vetted, higher-accountability inventory.
The trend: Baidu's arc from health-ad scandal to record profit drop to years of shrinking search revenue marks the broader shift of ad-dependent platforms trading short-term ad volume for regulatory survival.